Synergistic Effect of Lutein Combined With 5‐Fluorouracil‐Encapsulated Niosomes for Breast Cancer Treatment
Advances in Pharmacological and Pharmaceutical Sciences · 2026-01 · 2026 (1)
DOI: 10.1155/adpp/8533307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Pharmacological and Pharmaceutical Sciences, online erschienen am 12.04.2026. Verfasst von Southamany Sisavengsouk und 8 weiteren Autor:innen. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Silpakorn University.
Abstract (Originalsprache)
Breast cancer remains the most prevalent cancer in women globally, with cases projected to exceed 3 million by 2040. Current treatments, including chemotherapy with 5‐fluorouracil (5FU), are often hindered by multidrug resistance (MDR) and significant toxicities. This study investigated the potential of lutein (Lut), a bioactive xanthophyll with pro‐oxidant activity that could enhance 5FU’s efficacy while reducing the dosage in MCF‐7 cells analyzed via CompuSyn software. The result revealed that the Lut:5FU combination at a ratio of 0.25:1 had a synergistic effect at Fraction affected (Fa) of 0.49 with a combination index (CI) value of 0.09, indicating synergistic effects (CI < 1), and the dose‐reduction index (DRI) of Lut and 5FU was 11.27‐ and 277.16‐fold, respectively. Moreover, Lut encapsulation in niosomes could protect Lut’s photodegradation, offer controlled release, and enhance cancer cell inhibition. In addition, the total cell death of Lut:5FU encapsulated in niosomes (Lut:5FU‐N) was investigated by apoptosis assay, which was the highest efficacy at 43.11 ± 3.29% compared to Lut encapsulated in niosomes (Lut‐N) and 5FU encapsulated in niosomes (5FU‐N) as a single treatment (32.27 ± 1.17 and 24.97 ± 1.96%, respectively). This study presented that Lut could improve the therapeutic efficacy of 5FU by combination and encapsulation in niosomes for breast cancer treatment, providing a promising strategy to enhance anticancer effects, address the limitations of conventional cytotoxic agents, and mitigate associated toxicities.
Förderung
- Silpakorn University
Zitieren
APA
Sisavengsouk, S., Charoenying, T., Pamornpathomkul, B., Pornpitchanarong, C., Suriyaamporn, P., Kansom, T., Rojanarata, T., Opanasopit, P., & Pengnam, S. (2026). Synergistic Effect of Lutein Combined With 5‐Fluorouracil‐Encapsulated Niosomes for Breast Cancer Treatment. Advances in Pharmacological and Pharmaceutical Sciences, 2026(1). https://doi.org/10.1155/adpp/8533307
Vancouver
Sisavengsouk S, Charoenying T, Pamornpathomkul B, Pornpitchanarong C, Suriyaamporn P, Kansom T, et al. Synergistic Effect of Lutein Combined With 5‐Fluorouracil‐Encapsulated Niosomes for Breast Cancer Treatment. Advances in Pharmacological and Pharmaceutical Sciences. 2026;2026(1). doi:10.1155/adpp/8533307
BibTeX
@article{Sisavengsouk2026,
author = {Sisavengsouk, Southamany and Charoenying, Thapakorn and Pamornpathomkul, Boonnada and Pornpitchanarong, Chaiyakarn and Suriyaamporn, Phuvamin and Kansom, Teeratas and Rojanarata, Theerasak and Opanasopit, Praneet and Pengnam, Supusson},
title = {Synergistic Effect of Lutein Combined With 5‐Fluorouracil‐Encapsulated Niosomes for Breast Cancer Treatment},
journal = {Advances in Pharmacological and Pharmaceutical Sciences},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/adpp/8533307}
}
EUVIMED